-
Something wrong with this record ?
Influence of experimental end point on the therapeutic efficacy of the antinicotinic compounds MB408, MB442 and MB444 in treating nerve agent poisoned mice - a comparison with oxime-based treatment
J. Kassa, CM. Timperley, M. Bird, AC. Green, JEH. Tattersall
Language English Country Great Britain
Document type Comparative Study, Journal Article
- MeSH
- Antidotes pharmacology MeSH
- Time Factors MeSH
- Chemical Warfare Agents toxicity MeSH
- Lethal Dose 50 MeSH
- Mice MeSH
- Nicotinic Antagonists pharmacology MeSH
- Organophosphates toxicity MeSH
- Organophosphorus Compounds toxicity MeSH
- Organophosphate Poisoning drug therapy etiology MeSH
- Oximes pharmacology MeSH
- Pyridinium Compounds pharmacology MeSH
- Cholinesterase Reactivators pharmacology MeSH
- Sarin toxicity MeSH
- Soman toxicity MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
Therapeutic efficacy of antidotal treatment of acute poisoning by nerve agents is generally assessed by the evaluation of LD50 values of nerve agents over 24 h following poisoning without or with a single administration of antidotal treatment. In this study, LD50 values of four nerve agents (sarin, soman, tabun and cyclosarin) for non-treated and treated poisoning were evaluated in mice for two experimental end points - 6 h and 24 h. While the efficacy of atropine or oxime-based antidotal treatment was the same regardless of the experimental end point, the therapeutic efficacy of all three newly developed bispyridinium non-oxime compounds (MB408, MB442, and MB444) was mostly slightly higher at the 6 h end point compared to the 24 h end point, although the therapeutic efficacy of MB compounds was not superior to oxime-based antidotal treatment. These results contrast with a study in guinea-pigs using a structurally-related compound, MB327, which showed a striking increase in protection at 6 h compared to 24 h. It is suggested that the disparity may be due to pharmacokinetic differences between the two animal species.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019941
- 003
- CZ-PrNML
- 005
- 20210830101540.0
- 007
- ta
- 008
- 210728s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/15376516.2020.1817218 $2 doi
- 035 __
- $a (PubMed)32878547
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kassa, Jiri $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
- 245 10
- $a Influence of experimental end point on the therapeutic efficacy of the antinicotinic compounds MB408, MB442 and MB444 in treating nerve agent poisoned mice - a comparison with oxime-based treatment / $c J. Kassa, CM. Timperley, M. Bird, AC. Green, JEH. Tattersall
- 520 9_
- $a Therapeutic efficacy of antidotal treatment of acute poisoning by nerve agents is generally assessed by the evaluation of LD50 values of nerve agents over 24 h following poisoning without or with a single administration of antidotal treatment. In this study, LD50 values of four nerve agents (sarin, soman, tabun and cyclosarin) for non-treated and treated poisoning were evaluated in mice for two experimental end points - 6 h and 24 h. While the efficacy of atropine or oxime-based antidotal treatment was the same regardless of the experimental end point, the therapeutic efficacy of all three newly developed bispyridinium non-oxime compounds (MB408, MB442, and MB444) was mostly slightly higher at the 6 h end point compared to the 24 h end point, although the therapeutic efficacy of MB compounds was not superior to oxime-based antidotal treatment. These results contrast with a study in guinea-pigs using a structurally-related compound, MB327, which showed a striking increase in protection at 6 h compared to 24 h. It is suggested that the disparity may be due to pharmacokinetic differences between the two animal species.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antidota $x farmakologie $7 D000931
- 650 _2
- $a chemické bojové látky $x toxicita $7 D002619
- 650 _2
- $a reaktivátory cholinesterasy $x farmakologie $7 D002801
- 650 _2
- $a LD50 $7 D007928
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a nikotinoví antagonisté $x farmakologie $7 D018733
- 650 _2
- $a otrava organofosfáty $x farmakoterapie $x etiologie $7 D062025
- 650 _2
- $a organofosfáty $x toxicita $7 D010755
- 650 _2
- $a organofosforové sloučeniny $x toxicita $7 D009943
- 650 _2
- $a oximy $x farmakologie $7 D010091
- 650 _2
- $a pyridinové sloučeniny $x farmakologie $7 D011726
- 650 _2
- $a sarin $x toxicita $7 D012524
- 650 _2
- $a soman $x toxicita $7 D012999
- 650 _2
- $a časové faktory $7 D013997
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Timperley, Christopher M $u Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory (DSTL), Salisbury, United Kingdom
- 700 1_
- $a Bird, Mike $u Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory (DSTL), Salisbury, United Kingdom
- 700 1_
- $a Green, A Christopher $u Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory (DSTL), Salisbury, United Kingdom
- 700 1_
- $a Tattersall, John E H $u Chemical, Biological and Radiological Division, Defence Science and Technology Laboratory (DSTL), Salisbury, United Kingdom
- 773 0_
- $w MED00007380 $t Toxicology mechanisms and methods $x 1537-6524 $g Roč. 30, č. 9 (2020), s. 703-710
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32878547 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101540 $b ABA008
- 999 __
- $a ok $b bmc $g 1690693 $s 1140387
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 30 $c 9 $d 703-710 $e 20200920 $i 1537-6524 $m Toxicology mechanisms and methods $n Toxicol Mech Methods $x MED00007380
- LZP __
- $a Pubmed-20210728